How many institutional investors hold MIRM?

3 tracked institutional investors disclosed a position in MIRM (MIRUM PHARMACEUTICALS INC) in their most recent 13F filing.

Who is the largest institutional holder of MIRM?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in MIRM, valued at $98M.

Did institutional ownership of MIRM increase or decrease?

Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited MIRM.

Where does this MIRM ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

MIRM — MIRUM PHARMACEUTICALS INC

Name: MIRUM PHARMACEUTICALS INC (MIRM) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About MIRUM PHARMACEUTICALS INC (MIRM)

MIRUM PHARMACEUTICALS INC (MIRM) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $98M. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in MIRM

/100

Mixed Activity

Added / Increased0

Reduced0

Exited0

No recent activity recorded.

Crowded Trade Score™

How many top investors track MIRM

/100

Emerging Interest

3investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

MIRM Ownership Composition

How MIRUM PHARMACEUTICALS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

80% of tracked value

Institutions

tracked investors

Total Reported

$165M

combined 13F value

Other80.2%
Hedge Funds19.8%

Other(2)

80.2%

Hedge Funds(1)

19.8%

Tracked investors reporting MIRM

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	1.1M	$98.3M	0.02%	Mar 31, 2026
Izzy Englander	Millennium Management	368.6K	$34M	0.01%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	353.6K	$32.7M	0.04%	Mar 31, 2026

Ken GriffinMar 31, 2026
Citadel Advisors
Shares
1.1M
Value
$98.3M
% Portfolio
0.02%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
368.6K
Value
$34M
% Portfolio
0.01%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
353.6K
Value
$32.7M
% Portfolio
0.04%

Recent activity

Investor	Action	Δ %	Current value	Filing date
No recent activity.

No recent activity.

Frequently asked questions

How many institutional investors hold MIRM?: 3 tracked institutional investors disclosed a position in MIRM (MIRUM PHARMACEUTICALS INC) in their most recent 13F filing.
Who is the largest institutional holder of MIRM?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in MIRM, valued at $98M.
Did institutional ownership of MIRM increase or decrease?: Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited MIRM.
Where does this MIRM ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.